SASCM guideline for daptomycin use in South Africa – 2017 update
Daptomycin is currently registered for use in treatment of complicated skin and skin structure infections (cSSSI) and Staphylococcus aureus bacteraemia. The role of daptomycin in treatment of severe Gram-positive infections needs to be considered outside of these specific and rigid indications. Base...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2017-07-01
|
| Series: | Southern African Journal of Infectious Diseases |
| Subjects: | |
| Online Access: | https://sajid.co.za/index.php/sajid/article/view/58 |
| _version_ | 1811331457693515776 |
|---|---|
| author | Warren Lowman Jennifer Coetzee Olga Perovic |
| author_facet | Warren Lowman Jennifer Coetzee Olga Perovic |
| author_sort | Warren Lowman |
| collection | DOAJ |
| description | Daptomycin is currently registered for use in treatment of complicated skin and skin structure infections (cSSSI) and Staphylococcus aureus bacteraemia. The role of daptomycin in treatment of severe Gram-positive infections needs to be considered outside of these specific and rigid indications. Based on surveillance data, supporting literature and within the context of antimicrobial stewardship, the South African Society for Clinical Microbiology (SASCM) provides recommendations for appropriate use of daptomycin. These recommendations were formulated by members of the National Antimicrobial Committee (NAC), a
sub-committee of SASCM, following consultation and review of the relevant literature. |
| first_indexed | 2024-04-13T16:20:41Z |
| format | Article |
| id | doaj.art-4635d4b9dad54097a29605a35639036f |
| institution | Directory Open Access Journal |
| issn | 2312-0053 2313-1810 |
| language | English |
| last_indexed | 2024-04-13T16:20:41Z |
| publishDate | 2017-07-01 |
| publisher | AOSIS |
| record_format | Article |
| series | Southern African Journal of Infectious Diseases |
| spelling | doaj.art-4635d4b9dad54097a29605a35639036f2022-12-22T02:39:56ZengAOSISSouthern African Journal of Infectious Diseases2312-00532313-18102017-07-01322778110.4102/sajid.v32i2.5852SASCM guideline for daptomycin use in South Africa – 2017 updateWarren Lowman0Jennifer Coetzee1Olga Perovic2Vermaak and Partners Pathologists, Pretoria, South Africa; Ampath, National Reference Laboratory, Microbiology, Pretoria, South Africa;Department of Clinical Microbiology and Infectious Diseases, University of Witwatersrand, JohannesburgAmpath, National Reference Laboratory, Microbiology, PretoriaNational Institute for Communicable Diseases, Centre for Tropical, Opportunistic and Hospital Infections, Johannesburg, South Africa; Department of Clinical Microbiology and Infectious Diseases, University of Witwatersrand, JohannesburgDaptomycin is currently registered for use in treatment of complicated skin and skin structure infections (cSSSI) and Staphylococcus aureus bacteraemia. The role of daptomycin in treatment of severe Gram-positive infections needs to be considered outside of these specific and rigid indications. Based on surveillance data, supporting literature and within the context of antimicrobial stewardship, the South African Society for Clinical Microbiology (SASCM) provides recommendations for appropriate use of daptomycin. These recommendations were formulated by members of the National Antimicrobial Committee (NAC), a sub-committee of SASCM, following consultation and review of the relevant literature.https://sajid.co.za/index.php/sajid/article/view/58antimicrobial stewardshipantimicrobial therapydaptomycingram-positive infections |
| spellingShingle | Warren Lowman Jennifer Coetzee Olga Perovic SASCM guideline for daptomycin use in South Africa – 2017 update Southern African Journal of Infectious Diseases antimicrobial stewardship antimicrobial therapy daptomycin gram-positive infections |
| title | SASCM guideline for daptomycin use in South Africa – 2017 update |
| title_full | SASCM guideline for daptomycin use in South Africa – 2017 update |
| title_fullStr | SASCM guideline for daptomycin use in South Africa – 2017 update |
| title_full_unstemmed | SASCM guideline for daptomycin use in South Africa – 2017 update |
| title_short | SASCM guideline for daptomycin use in South Africa – 2017 update |
| title_sort | sascm guideline for daptomycin use in south africa 2017 update |
| topic | antimicrobial stewardship antimicrobial therapy daptomycin gram-positive infections |
| url | https://sajid.co.za/index.php/sajid/article/view/58 |
| work_keys_str_mv | AT warrenlowman sascmguidelinefordaptomycinuseinsouthafrica2017update AT jennifercoetzee sascmguidelinefordaptomycinuseinsouthafrica2017update AT olgaperovic sascmguidelinefordaptomycinuseinsouthafrica2017update |